Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: Population based study

British Medical Journal

Volumn 335, Issue 7625, 2007, Pages 875-878

  Bleich, Sara N ^a   Cutler, David M ^b   Adams, Alyce S ^c   Lozano, Rafael ^d   Murray, Christopher J L ^e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d SECRETARÍA DE SALUD   (Mexico)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEALTH PRACTITIONER; HUMAN; HYPERTENSION; INSURANCE; MAJOR CLINICAL STUDY; MALE; MEXICO; POPULATION RESEARCH; PRIORITY JOURNAL;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; FEMALE; HEALTH MANPOWER; HUMANS; HYPERTENSION; INSURANCE, HEALTH; MALE; MEDICALLY UNINSURED; MEXICO; MIDDLE AGED;

EID: 35948979271     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39350.617616.BE     Document Type: Article

References (14)

1. He J, Muntner P, Roccella EJ, Streiffer RH, Whelton PK. Factors associated with hypertension control in the general population of the United States. Arch Intern Med 2002;162(9):1051-8.
2. Huttin C, Moeller JE, Stafford RS. Patterns and costs for hypertension treatment in the United States: clinical, lifestyle and socioeconomic predictors from the 1987 National Medical Expenditures Survey. Clin Drug Investig 2000;20:181-95.
3. Levine DM. Adherence to antihypertensive therapy. In: Izzo JL, Black HR, eds. Hypertension primer from the Council on High Blood Pressure Research. Dallas: American Heart Association, 1993:291-3.
4. Moy E, Bartman BA, Weir MR. Access to hypertensive care. Effects of income, insurance, and source of care. Arch Intern Med 1995;155:1497-502.
5. Shea S, Misra D, Ehrlich MH, Held L, Francis CK. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med 1992;327:776-81.
6. Secretaria de Hacienda y Crédito Público de México. Segunda Resolución de Modificaciones a la Resolución Miscelánea Fiscal para 2003. Diario Oficial de la Federación. www.dof.gob.mx/2003/mayo/dof_15-05-2003.pdf.
7. Secretaría de Salud, Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición 2005 (ENSANut) 2006.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2007;42:1206-52.
9. Whitworth JA, World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92.
10. Ministry of Health. Subsistema de Information de Equipamiento, Recursos Humanos e Infraestructura para la Atención de la Salud (SINERHIAS) 2005.
11. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Ass 1984;79:516-24.
12. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
13. Gakidou E, Lozano R, González-Pier E, Abbott-Klafter J, Barofsky J, Bryson-Cahn C, et al. Assessing the effect of the 2001-06 Mexican health reform: an interim report card. Lancet 2006;368:1920-35.
14. He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J 1999;138(3):S211-9.